Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 18 December 2012
Vol. 5, Issue 255, p. ra92
[DOI: 10.1126/scisignal.2003184]

RESEARCH ARTICLES

Editor's Summary

Deadly Receptor Blockade
When bound to insulin-like growth factor 1 or 2 (IGF-1/2), the IGF-1 receptor (IGF1R) promotes protein synthesis, cell growth, and survival. One mechanism by which the family of IGF-binding proteins (IGFBPs) interferes with IGF1R activation is by binding to IGF-1/2. Evdokimova et al. showed that, unlike other IGFBPs, IGFBP7 attenuated activation of IGF1R in various cell lines by interacting with the extracellular domain of IGF1R and preventing IGF-1/2 from binding to the receptor. IGFBP7 increased the abundance of IGF1R in various normal and cancer cells and xenograft tumors. However, in cultured cells, IGFBP7 treatment resulted in the retention of IGF1R at the cell surface in an inactive form and in apoptosis. Thus, IGFBP7 could be used to trigger cell death in tumors that depend on IGF-1/2 for growth or survival.

Citation: V. Evdokimova, C. E. Tognon, T. Benatar, W. Yang, K. Krutikov, M. Pollak, P. H. B. Sorensen, A. Seth, IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors. Sci. Signal. 5, ra92 (2012).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma.
X. Tian, L. Zhang, L. Sun, Y. Xue, and S. Xie (2014)
Journal of International Medical Research
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882